Logo image of NRGX

PIMCO ENRGY & TACT CRDT OPP (NRGX) Stock Price, Quote, News and Overview

NYSE:NRGX - New York Stock Exchange, Inc. - US69346N1072 - Currency: USD

20.26  +0.2 (+1%)

Fundamental Rating

2

Taking everything into account, NRGX scores 2 out of 10 in our fundamental rating. NRGX was compared to 0 industry peers in the Unkown industry. NRGX may be in some trouble as it scores bad on both profitability and health. NRGX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year NRGX was profitable.
NRGX had a negative operating cash flow in the past year.
NRGX Yearly Net Income VS EBIT VS OCF VS FCFNRGX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 0 -500M -1B

1.2 Ratios

Industry RankSector Rank
ROA 13.4%
ROE 18.88%
ROIC 1.34%
ROA(3y)-13.16%
ROA(5y)N/A
ROE(3y)-18.07%
ROE(5y)N/A
ROIC(3y)2.34%
ROIC(5y)N/A
NRGX Yearly ROA, ROE, ROICNRGX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 0 -50 -100

1.3 Margins

In the last couple of years the Profit Margin of NRGX has grown nicely.
In the last couple of years the Operating Margin of NRGX has grown nicely.
In the last couple of years the Gross Margin of NRGX has grown nicely.
Industry RankSector Rank
OM 52.45%
PM (TTM) 425.46%
GM 51.85%
OM growth 3Y3.66%
OM growth 5YN/A
PM growth 3Y32.32%
PM growth 5YN/A
GM growth 3Y3.55%
GM growth 5YN/A
NRGX Yearly Profit, Operating, Gross MarginsNRGX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 0 500 -500 1K -1K

More info and screens

1

2. Health

2.1 Basic Checks

NRGX has about the same amout of shares outstanding than it did 1 year ago.
Compared to 1 year ago, NRGX has a worse debt to assets ratio.
NRGX Yearly Shares OutstandingNRGX Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 10M 20M 30M 40M
NRGX Yearly Total Debt VS Total AssetsNRGX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 200M 400M 600M 800M 1B

2.2 Solvency

NRGX has an Altman-Z score of 1.54. This is a bad value and indicates that NRGX is not financially healthy and even has some risk of bankruptcy.
NRGX has a Debt/Equity ratio of 0.37. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Altman-Z 1.54
ROIC/WACCN/A
WACCN/A
NRGX Yearly LT Debt VS Equity VS FCFNRGX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 0 500M -500M -1B

2.3 Liquidity

A Current Ratio of 0.42 indicates that NRGX may have some problems paying its short term obligations.
NRGX has a Quick Ratio of 0.42. This is a bad value and indicates that NRGX is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.42
Quick Ratio 0.42
NRGX Yearly Current Assets VS Current LiabilitesNRGX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 100M 200M 300M 400M

More info and screens

4

3. Growth

3.1 Past

NRGX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -42.98%.
Measured over the past years, NRGX shows a very strong growth in Earnings Per Share. The EPS has been growing by 51.85% on average per year.
Looking at the last year, NRGX shows a very strong growth in Revenue. The Revenue has grown by 37.79%.
Measured over the past years, NRGX shows a quite strong growth in Revenue. The Revenue has been growing by 14.87% on average per year.
EPS 1Y (TTM)-42.98%
EPS 3Y51.85%
EPS 5YN/A
EPS Q2Q%112.32%
Revenue 1Y (TTM)37.79%
Revenue growth 3Y14.87%
Revenue growth 5YN/A
Sales Q2Q%26.79%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NRGX Yearly Revenue VS EstimatesNRGX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 10M 20M 30M 40M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

NRGX is valuated cheaply with a Price/Earnings ratio of 6.01.
NRGX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.32.
Industry RankSector Rank
PE 6.01
Fwd PE N/A
NRGX Price Earnings VS Forward Price EarningsNRGX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NRGX Per share dataNRGX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

NRGX has a Yearly Dividend Yield of 5.73%, which is a nice return.
NRGX's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 5.73%

5.2 History

On average, the dividend of NRGX grows each year by 30.84%, which is quite nice.
NRGX has been paying a dividend for over 5 years, so it has already some track record.
NRGX has decreased its dividend recently.
Dividend Growth(5Y)30.84%
Div Incr Years1
Div Non Decr Years1
NRGX Yearly Dividends per shareNRGX Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 0.2 0.4 0.6 0.8 1

5.3 Sustainability

NRGX pays out 24.61% of its income as dividend. This is a sustainable payout ratio.
DP24.61%
EPS Next 2YN/A
EPS Next 3YN/A
NRGX Yearly Income VS Free CF VS DividendNRGX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 0 -500M -1B
NRGX Dividend Payout.NRGX Dividend Payout, showing the Payout Ratio.NRGX Dividend Payout.PayoutRetained Earnings

More info and screens

PIMCO ENRGY & TACT CRDT OPP

NYSE:NRGX (11/20/2023, 8:26:40 PM)

20.26

+0.2 (+1%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners51.04%
Inst Owner Change10.68%
Ins Owners6.08%
Ins Owner Change0%
Market Cap905.82M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.73%
Yearly Dividend0.73
Dividend Growth(5Y)30.84%
DP24.61%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 6.01
Fwd PE N/A
P/S 25.57
P/FCF N/A
P/OCF N/A
P/B 1.13
P/tB 1.13
EV/EBITDA N/A
EPS(TTM)3.37
EY16.63%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.56
FCFYN/A
OCF(TTM)-1.56
OCFYN/A
SpS0.79
BVpS17.86
TBVpS17.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 13.4%
ROE 18.88%
ROCE 2.32%
ROIC 1.34%
ROICexc 1.35%
ROICexgc 1.37%
OM 52.45%
PM (TTM) 425.46%
GM 51.85%
FCFM N/A
ROA(3y)-13.16%
ROA(5y)N/A
ROE(3y)-18.07%
ROE(5y)N/A
ROIC(3y)2.34%
ROIC(5y)N/A
ROICexc(3y)2.36%
ROICexc(5y)N/A
ROICexgc(3y)2.4%
ROICexgc(5y)N/A
ROCE(3y)3.32%
ROCE(5y)N/A
ROICexcg growth 3Y31.74%
ROICexcg growth 5YN/A
ROICexc growth 3Y31.69%
ROICexc growth 5YN/A
OM growth 3Y3.66%
OM growth 5YN/A
PM growth 3Y32.32%
PM growth 5YN/A
GM growth 3Y3.55%
GM growth 5YN/A
F-Score4
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 6.38
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.42
Quick Ratio 0.42
Altman-Z 1.54
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-42.98%
EPS 3Y51.85%
EPS 5YN/A
EPS Q2Q%112.32%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)37.79%
Revenue growth 3Y14.87%
Revenue growth 5YN/A
Sales Q2Q%26.79%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y18.39%
EBIT growth 3Y19.07%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-114.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-114.3%
OCF growth 3YN/A
OCF growth 5YN/A